{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:22:12Z","timestamp":1789824132415,"version":"4.0.1"},"reference-count":28,"publisher":"Walter de Gruyter GmbH","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p\/><jats:p\/><jats:p\/><jats:p\/><jats:p\/><jats:p>Clin Chem Lab Med 2006;44:949\u201354.<\/jats:p>","DOI":"10.1515\/cclm.2006.184","type":"journal-article","created":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T19:32:27Z","timestamp":1154460747000},"source":"Crossref","is-referenced-by-count":2,"title":["Association of aminothiols with the clinical outcome in hemodialysis patients: comparison of chromatography and immunoassay for homocysteine determination"],"prefix":"10.1515","volume":"44","author":[{"given":"St\u00e9phanie","family":"Badiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Jaussent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Naudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Leray-Moragues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Rivory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Delcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Canaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Cristol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0741-5214(98)70069-2","article-title":"Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model","volume":"28","author":"Southern","year":"1998","journal-title":"J Vasc Surg"},{"key":"ref21","first-page":"405","article-title":"Plasma homocysteine levels and cardiovascular mortality in patients with end - stage renal disease","volume":"17","author":"Buccianti","year":"2004","journal-title":"J Nephrol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1681\/ASN.V61121","article-title":"Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients","volume":"6","author":"Bachmann","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1515\/CCLM.2003.102","article-title":"Hyperhomocysteinemia and end - stage renal disease : determinants and association with cardiovascular disease in Tunisian patients","volume":"41","author":"Fellah","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s007260170039","article-title":"Detection of moderate hyperhomocysteinemia : comparison of the Abbott fluorescence polarization immunoassay with the Bio - Rad and SBD - F high - performance liquid chromatographic assays","volume":"20","author":"Barbe","year":"2001","journal-title":"Amino Acids"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00002480-199410000-00017","article-title":"Simple Kt \/ V formulas based on urea mass balance theory","volume":"40","author":"Garred","year":"1994","journal-title":"ASAIO J"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.ASN.0000107564.60018.51","article-title":"A low , rather than a high , total plasma homocysteine is an indicator of poor outcome in hemodialysis patients","volume":"15","author":"Kalantar","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1523-1755.2002.00144.x","article-title":"Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients","volume":"61","author":"Mallamaci","year":"2002","journal-title":"Kidney Int"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.97.2.138","article-title":"Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end - stage renal disease","volume":"97","author":"Moustapha","year":"1998","journal-title":"Circulation"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1081\/JDI-200037117","article-title":"Homocysteine and vascular access thrombosis in a cohort of end - stage renal disease patients","volume":"26","author":"Bowden","year":"2004","journal-title":"Ren Fail"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1515\/CCLM.2004.041","article-title":"Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay on the AxSYM analyzer","volume":"42","author":"Lonati","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"497","DOI":"10.33549\/physiolres.930514","article-title":"Intima media thickness of common carotid arteries is associated with traditional risk factors and presence of ischaemic heart disease in hemodialysis patients","volume":"54","author":"Brzosko","year":"2005","journal-title":"Physiol Res"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0272-6386(04)00815-7","article-title":"Hyperhomocysteinemia in relation to plasma free amino acids , biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy","volume":"44","author":"Suliman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref251","first-page":"411","article-title":"The achievement of normal homocysteinemia in regular extracorporeal dialysis patients","volume":"17","author":"Gonella","year":"2004","journal-title":"J Nephrol"},{"key":"ref111","first-page":"393","article-title":"Comparison of three methods for total homocysteine plasma determination","volume":"47","author":"Brunelli","year":"2001","journal-title":"Clin Lab"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","article-title":"Advanced coronary and carotid arteriopathy in young adults with childhood - onset chronic renal failure","volume":"106","author":"Oh","year":"2002","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1389200052997357","article-title":"Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function","volume":"6","author":"Weiss","year":"2005","journal-title":"Curr Drug Metab"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/CCLM.2000.047","article-title":"Comparison of the Abbott IMx and a high - performance liquid chromatography method for measuring total plasma homocysteine","volume":"38","author":"Blanco","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1570-0232(02)00497-X","article-title":", SFBC working group on homocysteine French Society for Clinical Biology Methods for homocysteine analysis and biological relevance of the results","volume":"781","author":"Ducros","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2004.04.002","article-title":"Homocysteine and carotid atherosclerosis in chronic renal failure the confounding effect of renal function","volume":"175","author":"Leskinen","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ndt\/17.6.1050","article-title":"Influence of nutritional status on plasma and erythrocyte sulphur amino acids , sulph - hydryls , and inorganic sulphate in end - stage renal disease Nephrol","volume":"17","author":"Suliman","year":"2002","journal-title":"Dial Transplant"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end - stage renal disease and is closely linked to plasma folate and pyridoxine concentrations","volume":"94","author":"Robinson","year":"1996","journal-title":"Circulation"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2000-8407","article-title":"Homocysteine and renal disease","volume":"26","author":"Van Guldener","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1515\/CCLM.2001.112","article-title":"Total plasma homocysteine and related amino acids in end - stage renal disease patients measured by gas chromatography - mass spectrometry comparison with the Abbott IMx homocysteine assay and the HPLC method","volume":"39","author":"Sigit","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/clinchem\/48.9.1539","article-title":"Interlaboratory variation of plasma total homocysteine measurements : results of three successive homocysteine proficiency testing surveys","volume":"48","author":"Hanson","year":"2002","journal-title":"Clin Chem"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1191\/096228099673819272","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.ki.5000447","article-title":"Mortality risk for patients receiving hemodiafiltration versus hemodialysis : European results from the DOPPS","volume":"69","author":"Canaud","year":"2006","journal-title":"Kidney Int"},{"key":"ref41","first-page":"63","article-title":"Relationship between endothelial dysfunction and serum homocysteine in patients with coronary lesions","volume":"20","author":"Chen","year":"2005","journal-title":"Chin Med Sci J"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2006.44.issue-8\/cclm.2006.184\/cclm.2006.184.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2006.184\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T10:39:44Z","timestamp":1683542384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2006.184\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":28,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.1515\/cclm.2006.184","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}